GDPD5 and neoplasm: MiR-874-3p targets glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5), and the upregulation of GDPD5 reverses the miR-874-3p-triggered tumor inhibition and ferroptosis promotion (Wang et al., 2021a).